Money flow gives a snapshot of relative buying and selling pressure in a stock. A ratio above one suggests greater buying pressure, below one suggests greater selling.
| Company | Change | P/E (TTM) |
|---|---|---|
TACTTransAct Technologies Inc. | -2.14% | 19.26 |
MRCYMercury Systems Inc. | +0.69% | 44.98 |
ALOTAstroNova Inc. | +1.08% | 24.93 |
ACTGAcacia Research Corp. - Acacia Technologies | -1.53% | - |
ESCCEvans & Sutherland Computer Corp. | +8.15% | 31.81 |
RPXCRPX Corp. | -0.65% | 26.55 |
QUMUQumu Corp. | +12.33% | - |
CRWECrown Equity Holdings Inc. | - | - |
LINKInterlink Electronics | - | 31.78 |
ITUS Corp. is a pharmaceutical company, through its subsidiary, Anixa Diagnostics Corp. develops non-invasive blood tests for the early detection of solid tumor based cancers. The company was founded by Denis A. Krusos on November 5, 1982 and is headquartered in Los...
| Q3 2016 Estimate Trends | |
|---|---|
| Current: | $- |
| 1 month ago: | $- |
| 3 months ago: | $- |
| Q4 2016 Estimate Trends | |
|---|---|
| Current: | $- |
| 1 month ago: | $- |
| 3 months ago: | $- |
| Jul 2016 | 5-quarter trend | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth | +31.11% | | ||||||||||
| Sales or Revenue | 100,000 | | ||||||||||
| Sales or Revenue Growth | +5.26% | |||||||||||
| EBITDA | -885,009 | | ||||||||||
| 2015 | 5-year trend | |||||||||||
| Net Income Growth | +85.64% | | ||||||||||
| Sales or Revenue | 255,000 | | ||||||||||
| Sales or Revenue Growth | -93.05% | | ||||||||||
| EBITDA | -6.12 M | |